Underwriting
  • Research and White Papers
  • April 2025

Smoke Signals: How insurers can uncover hidden tobacco use in the digital age

By
  • Guizhou Hu
  • Taylor Pickett
  • Jacqueline Waas
  • Rosmery Cruz
Skip to Authors and Experts
Woman looking at a study
In Brief

As accelerated underwriting becomes more mainstream, insurers face challenges detecting undisclosed tobacco use. Three RGA studies explore the effectiveness of various digital underwriting evidences and behavioral science techniques in identifying non-disclosed tobacco use, providing insights for enhanced risk assessment strategies.

See the article in Digital Insurance

Key takeaways

  • Undisclosed tobacco use is a growing and increasingly pressing problem for underwriters to address. 
  • Insurance labs remain the gold standard for identifying undisclosed tobacco use, but digital underwriting evidence offers a promising newer means to increase discovery.
  • Study findings highlight the value of integrating electronic health records (EHR) data early in the underwriting process and incorporating behavioral science techniques in designing application questions.

Yet something doesn't add up. Experience tells the underwriter that what she is seeing in the application indicates a smoker, yet the applicant says he has never used tobacco. In an era of accelerated underwriting and without the trusty cotinine test at her disposal, how can this underwriter confirm her suspicions?

This scenario, playing out in insurance offices across the country, underscores a growing challenge in the industry. In an increasingly digital landscape, detecting undisclosed tobacco use can be more difficult.

As the insurance world races towards faster, less invasive underwriting processes, it finds itself grappling with the critical question of how to effectively identify tobacco users through third-party evidence without traditional lab tests.

Thankfully, a combination of behavioral science techniques and new digital tools offers a solution to increase the likelihood of underwriters confirming their suspicions and improving disclosure rates.

The root of the challenge: Digitalization and disclosure

At the heart of this dilemma is a significant shift in underwriting practices. Cotinine test results were the underwriter's go-to for detecting tobacco use dating back to the 1960s. But these tests have become increasingly unpopular as insurers embrace accelerated underwriting and "fluidless" paths that improve the customer experience but eliminate the time needed for lab tests.

This transition, while streamlining the application process, has created a significant challenge in risk assessment, prompting a search for new methods that help increase discovery of non-disclosed tobacco use.

In response, researchers at Reinsurance Group of America (RGA) embarked on three comprehensive studies. The first examines how behavioral science techniques can improve disclosure rates without negatively impacting the applicant experience. The second and third explore the effectiveness of digital underwriting evidence in uncovering the truth behind the smoke screen. 

The findings: A two-pronged approach

Behavioral science techniques

Behavioral science is a multidisciplinary field of scientific study that seeks to discover the implications arising from the differences between what people say they do and what they actually do. Put simply, people’s actions don’t always match their words about their actions. 

Behavioral science techniques can draw forth more accurate self-reported disclosures. Research has shown that even small adjustments to certain questions on life insurance applications, informed by behavioral science principles, can mitigate some psychological sources of false disclosures, such as shame. Key findings from RGA behavioral science research on tobacco-related disclosures include:

  1. Destigmatize the behavior – Questions that asked, "When was the last time you smoked or used nicotine products?" with multiple response options led to significantly increased disclosure rates compared to questions worded, “Have you smoked or used nicotine products in the last two years?” By normalizing the behavior, respondents proved to be more likely to accurately disclosure their tobacco-use history. 
  2. Avoid obvious right/wrong answers – Asking “Have you smoked in the last two years?” makes the underwriting rule obvious and, hence, it is easier for applicants to fail to disclose the behavior. Asking “When was the last time you smoked or used nicotine products?” not only destigmatizes the behavior, it better cloaks the underwriting rule and, thus, encourages a more honest response. 
  3. Minimal impact on response time – The enhanced questions only added 2 to 2.5 seconds to the average response time, a negligible increase considering the improved disclosure rates.
  4. Positive applicant experience – There were no meaningful differences in perceived ease, speed, or confidence in accuracy between traditional and enhanced questions.

Questions framed in a manner to elicit more truthful responses provide the foundation on which to build the next layer to overcome limitations posed through self-disclosure. That layer deals with alternative evidences.

Woman typing on a red laptop
Learn more about behavioral science and how it can positively impact tobacco disclosures and more.

Digital evidence hierarchy

RGA's second study focused on electronic health records (EHRs), medical claims (MC), pharmacy prescriptions (Rx), and LabPiQture (LP), a product from ExamOne that provides both clinical and historical insurance lab results. The results paint a clear picture of the relative value of different evidence types for detecting tobacco use:

 
  1. Insurance labs – Despite the industry shift, traditional insurance labs remain the most effective method for identifying tobacco users.
  2. Electronic health records (EHRs) and attending physician statements (APSs) – Among digital evidence types, EHRs emerged as the strongest performer in detecting current tobacco use.
  3. Medical claims (MC) – While not as effective as EHRs, MC data proved to be a valuable source of information on tobacco use.
  4. LabPiQture (LP) – The effectiveness of LP in detecting tobacco use was directly tied to the presence of historical insurance lab results within the data.
  5. Prescription data (Rx) – Rx showed limited effectiveness in identifying tobacco use, with very few tobacco cessation medications found.

The third study found the value insurance labs add to LabPiQture to uncover tobacco use. LP hits with prior insurance labs will include a cotinine test result, thereby matching the valuable tobacco use detection of traditional insurance labs in all but recency.  One caveat is that the insurance labs housed within LP will likely not be as current as traditional insurance labs taken at the time of underwriting.

Figures 2 and 3 depict how LP smoking identification overlaps with self-disclosure, indicating that some smokers do indeed disclose tobacco use. Interestingly, we did not see the same overlap with MC or Rx. This adds another layer of reliability to the LP findings.

 
 
Cigarette in an ash tray
Dive deeper into the RGA research on uncovering hidden tobacco use through third-party underwriting evidences to help improve risk management.

Implications for insurers

The findings of these studies have significant implications for insurers looking to enhance their risk assessment processes in an age of accelerated underwriting:

  1. Implement behavioral science techniques – Incorporate enhanced question formats that break down complex inquiries into more digestible parts, destigmatizing the behavior, and avoiding binary questions that force yes/no answers. This can improve disclosure rates without significantly increasing response times or negatively impacting the applicant experience.
  2. Rethink simplicity in application design – Consider that visually longer questions may actually simplify the mental process for applicants, leading to more accurate disclosures and improved recall of behaviors.
  3. Prioritize EHR integration – Given the strong performance of EHRs in detecting current tobacco use, insurers should consider integrating this data source early in the underwriting process.
  4. Consider historical data – The value of past insurance lab results within LabPiQture data suggests that insurers should not totally disregard historical data in current risk assessments.
  5. Balance disclosure rates and user experience – When designing application questions, aim to strike a balance between improving disclosure rates and maintaining a positive user experience.

Conclusion: Adapting to a changing landscape

As the industry continues to evolve, staying informed about the latest research and best practices in risk assessment and application design will be crucial for insurers looking to maintain a competitive edge while effectively managing risk. The findings of these studies provide a valuable roadmap for navigating this new terrain, offering insights that can help shape more effective underwriting strategies in the digital age.

By embracing psychological insights and technological advancements, insurers can create more robust, accurate, and user-friendly underwriting processes that benefit both the industry and its customers.


More Like This...

Meet the Authors & Experts

Guizhou Hu
Author
Guizhou Hu
Vice President, Head of Risk Analytics, Global Underwriting, Claims, and Medical, RGA
Taylor Pickett
Author
Taylor Pickett
Vice President & Actuary, US Individual Life, RGA
Jackie-Waas
Author
Jacqueline Waas
Vice President, Underwriting Research and Development, US Individual Life
ROSEMARY CRUZ
Author
Rosmery Cruz
Executive Director, Behavioral Data Science, Global Research and Development, RGA